GSK Investigational Site is a clinical research site located in Arlington, Virginia, United States 22205-3606.
Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.
GSK Investigational Site has participated in 13 clinical trials.
Therapeutic areas: Systemic Lupus Erythematosus, Purpura, Thrombocytopaenic, Idiopathic, Bipolar Disorder.
Sponsors: GlaxoSmithKline, ViiV Healthcare, Human Genome Sciences Inc., a GSK Company.
Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
GSK Investigational Site has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GSK Investigational Site has 13 clinical trials on record. Their work covers Systemic Lupus Erythematosus, Purpura, Thrombocytopaenic, Idiopathic, Bipolar Disorder.
Yes — GSK Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.